Peritoneal Dialysis Complication Clinical Trial
Official title:
Characteristics and Clinical Outcomes of Peritoneal Dialysis Patients
NCT number | NCT05224466 |
Other study ID # | PD |
Secondary ID | |
Status | Not yet recruiting |
Phase | |
First received | |
Last updated | |
Start date | March 2022 |
Est. completion date | December 2024 |
Peritoneal dialysis patients worldwide account for about 11% of the global dialysis population. The global annual growth rate of peritoneal dialysis is estimated to be 8%, which is listed as the preferred method of renal replacement therapy in most countries. Although peritoneal dialysis has been widely used, due to complications such as peritoneal dialysis related infection, peritoneal ultrafiltration failure and EPS, the failure rate of peritoneal dialysis technology is high, and the 3-year technical survival rate is only 64%. Therefore, this study intends to explore clinical strategies for maintaining the long-term peritoneal dialysis by analyzing the clinical characteristics of patients , as well as the differences of risk factors affecting the survival rate of peritoneal dialysis technology at different time stages of peritoneal dialysis treatment.
Status | Not yet recruiting |
Enrollment | 400 |
Est. completion date | December 2024 |
Est. primary completion date | December 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - ESRD patients - The first time of peritoneal dialysis Exclusion Criteria: - Age <18 years at start of PD - Transfer or follow-up loss - Previous transplantation or HD history - Incomplete clinical data |
Country | Name | City | State |
---|---|---|---|
China | Shanghai Renji Hospital, Shanghai Jiaotong University School of Medicine | Shanghai | Shanghai |
Lead Sponsor | Collaborator |
---|---|
Shanghai Jiao Tong University School of Medicine |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | baseline clinical characteristics before PD | clinical characteristics about age,sex,comorbidities before PD,laboratory data would be aggregated from the existing record to find out the differences between the long-term PD patients and the others that may affect their clinical outcome. | within one month before the start of PD | |
Secondary | the factors that may lead to the termination of PD | Some patients may end the PD early ,some late due to many reasons.To find out the factors that may influence survival rate of peritoneal dialysis technology at different time stages of peritoneal dialysis treatment, the investigators collect and record the reasons for termination of PD to analyze. | up to 20 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04034628 -
Improving the Outcomes of Peritoneal Dialysis (PD) Catheter Insertion
|
||
Completed |
NCT03569410 -
The Effect of Natural Protein vs. Protein Supplements on Peritoneal Dialysis Patients
|
N/A | |
Completed |
NCT04302649 -
Dialysate Temperature in Peritoneal Dialysis
|
Phase 4 | |
Enrolling by invitation |
NCT05250752 -
Reduction of Peritoneal Glucose Uptake With Use of SGLT2 in Humans Undergoing Peritoneal Dialysis Treatment
|
Phase 2 | |
Recruiting |
NCT03563898 -
Feasibility and Safety in the Management of Fluid Overload in Peritoneal Dialysis Patients Through Sweat Stimulation With the Use of Portable Sauna Bath, Pilot Study
|
N/A | |
Recruiting |
NCT03046511 -
Peritonitis Prevention After Insertion of Peritoneal Dialysis Catheter.
|
Phase 3 | |
Completed |
NCT03458819 -
EMT in Peritoneal Dialysis Patients
|
||
Recruiting |
NCT06398977 -
Dapagliflozin Delays the Loss of Renal Function in Peritoneal Dialysis Patients
|
N/A | |
Not yet recruiting |
NCT06045858 -
SAFETY AND EFFICACY OF APIXABAN VERSUS WARFARIN IN PERITONEAL DIALYSIS PATIENTS WITH NON VALVULAR ATRIAL FIBRILLATION: A PROSPECTIVE, RANDOMISED, OPEN-LABEL, BLINDED END-POINT TRIAL (APIDP2)
|
Phase 3 | |
Active, not recruiting |
NCT04034966 -
Utility of Telemedicine in the Follow-Up of Patients in Peritoneal Dialysis
|
N/A | |
Completed |
NCT04923295 -
The Effect of Dapagliflozin on Ultrafiltration Among Peritoneal Dialysis Patients
|
N/A | |
Not yet recruiting |
NCT05715814 -
meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis
|
Phase 3 | |
Recruiting |
NCT03148002 -
Peritoneal Dialysis Pilot Study: Evaluating Polyethylene Glycol (PEG) for Constipation
|
Phase 4 | |
Recruiting |
NCT04572724 -
The Effect of Sacubitril/Valsartan on Cardiovascular Events in Dialysis Patients and Efficacy Prediction of Baseline LVEF Value
|
Phase 4 | |
Completed |
NCT05797181 -
The Effect Of Medical Nutritional Therapy On Patients With Sarcopenic Obesity Receiving Peritoneal Dialysis Treatment
|
N/A | |
Recruiting |
NCT01893710 -
International (Pediatric) Peritoneal Biobank
|
||
Completed |
NCT03382444 -
The Kidney and The Brain Study - Assessment of Cognitive Impairment in Advanced CKD
|
||
Completed |
NCT04046263 -
Effect of Velphoro on Serum Phosphate and Albumin in Peritoneal Dialysis Patients
|
Phase 4 | |
Completed |
NCT03759002 -
Association of Mean Platelet Volume and Cardiovascular Disease in Children With End Stage Renal Disease.
|
||
Completed |
NCT04176627 -
Assessing Fluid Status of Peritoneal Dialysis Patients With Assistance of Lung Ultrasound
|